★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarkets New Genomic Breakthroughs Could Spark a CRISPR Comeback and Renewed M&A Activity in Biotech Despite a prolonged sell-off in biotech stocks, the development of genomic medicine has continued apace. For just the third time,…McAlinden Research PartnersMay 23, 2022
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Gene Editing Firms Expand Potential Treatments by Shrinking Proteins, Focusing on RNA Research Research into CRISPR gene editing technology continues to expand the amount of potential applications, while shrinking the actual size of proteins…McAlinden Research PartnersSeptember 8, 2021